Understanding Nonreacting Substrate Analogs as Potential Scaffolds for Inhibitor Design Against Mycobacterium t uberculosis Cystathionine β‐Synthase
ChemBioChem · 26.11.2026 · 27 (22)
DOI: 10.1002/cbic.70603 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 16.11.2026. Verfasst von Sainath Polepalli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biophysics Unit, Indian Institute of Science, Bengaluru, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Enzyme Inhibitors, Cystathionine beta-Synthase, Drug Design. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Science and Engineering Research Board ( Anusandhan National Research Foundation, ANRF), Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Mycobacterium tuberculosis cystathionine beta‐synthase ( Mtb CBS), a pyridoxal‐5′‐phosphate (PLP)‐dependent enzyme, regulates sulfur metabolism and redox homeostasis, making it a model enzyme for inhibition studies and to understand scaffold behavior. Amino acids remains as an attractive scaffold for designing novel inhibitors having reduced cytotoxicity and improved properties for cellular uptake. This study integrates computational, biophysical, and structural approaches to provide for a potential scaffold that could be further modified to inhibit Mtb CBS. Structure‐based sequence alignment of CBS homologs identified seven conserved polar/charged regions critical for PLP‐substrate interactions. Molecular docking of polar substrate analogs (threonine, histidine, glutamic acid, and arginine) at the conserved active site revealed distinct binding modes for histidine, glutamic acid, and arginine. Molecular dynamics simulations demonstrated persistent binding of histidine, stabilized by hydrophobic interactions relative to other analogs. Experimental studies revealed histidine’s ability to form stable external aldimine adducts, modulating enzyme thermostability (Δ T m ), akin to known reacting substrates. Finally, cryo‐EM‐based structural studies revealed two classes of Mtb CBS, one with extra density suggesting the noncovalently bound histidine and the unbound WT Mtb CBS maintaining internal aldimine. This suggests that exploration of the chemical modification space of the histidine moiety might provide us with a potential inhibitor against Mtb CBS and enzymes of the RTS pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biophysics Unit, Indian Institute of Science, Bengaluru, India.
- Department of Microbiology and Cell Biology, Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India.
ORCID-Profile: Sainath Polepalli, Anupam Roy, Bapan Mondal, Prasenjit Naskar, Drose Ignatious Shane, Amit Singh, Somnath Dutta
Förderung
- Science and Engineering Research Board ( Anusandhan National Research Foundation, ANRF)
- Department of Biotechnology, Ministry of Science and Technology, India
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Polepalli, S., Roy, A., Mondal, B., Naskar, P., Shane, D. I., Singh, A., & Dutta, S. (2026). Understanding Nonreacting Substrate Analogs as Potential Scaffolds for Inhibitor Design Against Mycobacterium t uberculosis Cystathionine β‐Synthase. ChemBioChem, 27(22). https://doi.org/10.1002/cbic.70603
Vancouver
Polepalli S, Roy A, Mondal B, Naskar P, Shane DI, Singh A, et al. Understanding Nonreacting Substrate Analogs as Potential Scaffolds for Inhibitor Design Against Mycobacterium t uberculosis Cystathionine β‐Synthase. ChemBioChem. 2026;27(22). doi:10.1002/cbic.70603
BibTeX
@article{Polepalli2026,
author = {Polepalli, Sainath and Roy, Anupam and Mondal, Bapan and Naskar, Prasenjit and Shane, Drose Ignatious and Singh, Amit and Dutta, Somnath},
title = {Understanding Nonreacting Substrate Analogs as Potential Scaffolds for Inhibitor Design Against Mycobacterium t uberculosis Cystathionine β‐Synthase},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {22},
doi = {10.1002/cbic.70603}
}
EUVIMED